ELMD - רווח נקי למניה (EPS TTM) Electromed Inc

Sector stability and the strong social mission of Electromed, Inc. (ELMD) attract dedicated engineers to the team. Net income per share over 12 months clearly demonstrates the financial efficiency of this strategy, where 1.38 records the value of this parameter. The growth of the chronic patient base is driven by the expansion of Medicare insurance, while global operational support relies on contract manufacturing and outsourced services.

A comparative asset analysis requires evaluating the real yield of each security by calculating the net profit distributed across the total share volume over a rolling year. The trend in the TTM annual earnings per share for Electromed, Inc. (ELMD) reflects the monetization efficiency of patient loyalty to SmartVest systems, confirming the financial stability of the Electromed, Inc. (ELMD) brand within the chronic lung disease therapy segment.